ArticleJournal of cardiovascular translational research2026
Sex-Specific Prospective Association of Serum Zinc Concentration with Cardiovascular Disease and Mortality: A 10-Year Population-Based Cohort Study.
Article in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc is an essential trace element that plays a significant role in vascular function. This study aimed to investigate the potential association between serum zinc (SZn) concentration and cardiovascular disease (CVD) events, CVD mortality, and all-cause mortality, while also considering possible sex-specific differences. We analyzed data from 3,353 participants aged 30 years or older without a history of CVD, sourced from the fourth phase of the Tehran Lipid and Glucose Study (TLGS) conducted between 2009 and 2011. Multivariable Cox proportional hazard models were used. In men, low SZn levels were associated to a 94% increased risk of all-cause mortality (HR = 1.94, 95% CI = 1.03-3.65). Conversely, high SZn concentrations were associated with a reduced risk of CVD events (HR = 0.66, 95% CI = 0.46-0.93). No significant associations were observed in women. In men, low SZn was associated with higher all-cause mortality, whereas high SZn was inversely associated with CVD risk.
Indexed as
Identifiers
42262457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.